{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T01:20:10Z","timestamp":1772068810070,"version":"3.50.1"},"reference-count":254,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.micpath.2024.107116","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T20:23:33Z","timestamp":1731443013000},"page":"107116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Insights to the role of phytoconstituents in aiding multi drug resistance \u2013 Tuberculosis treatment strategies"],"prefix":"10.1016","volume":"198","author":[{"given":"Richi","family":"Goel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anush","family":"Tomar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2140-9270","authenticated-orcid":false,"given":"Sweta","family":"Bawari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2024.107116_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.tim.2018.02.012","article-title":"Mycobacterium tuberculosis","volume":"26","author":"Koch","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/11786361231152438","article-title":"Challenges & solutions for recent advancements in multi-drugs resistance tuberculosis: a review","volume":"16","author":"Yadav","year":"2023","journal-title":"Microbiol. Insights"},{"key":"10.1016\/j.micpath.2024.107116_bib3","series-title":"Global Tuberculosis Report 2013","author":"Organization","year":"2013"},{"key":"10.1016\/j.micpath.2024.107116_bib4","doi-asserted-by":"crossref","first-page":"l5770","DOI":"10.1136\/bmj.l5770","article-title":"Is Mycobacterium tuberculosis infection life long?","volume":"367","author":"Behr","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.micpath.2024.107116_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/aje\/152.3.247","article-title":"Lifetime risks, incubation period, and serial interval of tuberculosis","volume":"152","author":"Vynnycky","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.micpath.2024.107116_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5005\/ijcdas-56-4-237","article-title":"Multidrug resistant tuberculosis: trends and control","volume":"56","author":"Singh","year":"2022","journal-title":"Indian J. Chest Dis. Allied Sci."},{"key":"10.1016\/j.micpath.2024.107116_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijmmb.2022.10.008","article-title":"National TB elimination programme - what has changed","volume":"42","author":"Khanna","year":"2023","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib8","series-title":"Treatment of Tuberculosis: Guidelines","author":"Organization","year":"2010"},{"key":"10.1016\/j.micpath.2024.107116_bib9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1186\/1471-2458-13-782","article-title":"Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study","volume":"13","author":"Hirpa","year":"2013","journal-title":"BMC Publ. Health"},{"key":"10.1016\/j.micpath.2024.107116_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2458-11-19","article-title":"Does directly observed therapy (DOT) reduce drug resistant tuberculosis?","volume":"11","author":"Moonan","year":"2011","journal-title":"BMC Publ. Health"},{"key":"10.1016\/j.micpath.2024.107116_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089822","article-title":"Disease control implications of India's changing multi-drug resistant tuberculosis epidemic","volume":"9","author":"Suen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107116_bib12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4103\/0970-2113.217569","article-title":"Adverse drug reactions and treatment outcome analysis of DOTS-plus therapy of MDR-TB patients at district tuberculosis centre: a four year retrospective study","volume":"34","author":"Dela","year":"2017","journal-title":"Lung India"},{"issue":"Suppl 1","key":"10.1016\/j.micpath.2024.107116_bib13","first-page":"S12","article-title":"Update of drug-resistant tuberculosis treatment guidelines: a turning point","volume":"130","author":"Vanino","year":"2023","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"10.1016\/j.micpath.2024.107116_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1517\/14740338.5.2.231","article-title":"Adverse reactions to first-line antituberculosis drugs","volume":"5","author":"Forget","year":"2006","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.micpath.2024.107116_bib15","unstructured":"Guideline for PMDT in India 2017 \u2013 Central Tuberculosis Division, (n.d.). https:\/\/tbcindia-wp.azurewebsites.net\/guideline-for-pmdt-in-india-2017\/(accessed June 14, 2024)."},{"key":"10.1016\/j.micpath.2024.107116_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117594","article-title":"Tuberculosis vaccine: a journey from BCG to present","volume":"252","author":"Fatima","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.micpath.2024.107116_bib17","series-title":"Fight. Multidrug Resist. Herb. Extr. Essent. Oils Their Compon","first-page":"45","article-title":"Chapter 5 - plants and tuberculosis: phytochemicals potentially useful in the treatment of tuberculosis","author":"Kerr","year":"2013"},{"key":"10.1016\/j.micpath.2024.107116_bib18","series-title":"Stud. Nat. Prod. Chem.","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/B978-0-444-59530-0.00015-0","article-title":"Chapter 15 - phytochemicals: in pursuit of antitubercular drugs","author":"Veluthoor","year":"2012"},{"key":"10.1016\/j.micpath.2024.107116_bib19","series-title":"Definitions and Reporting Framework for Tuberculosis \u2013 2013 Revision: Updated December 2014 and January 2020","year":"2013"},{"key":"10.1016\/j.micpath.2024.107116_bib20","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.5588\/ijtld.15.0389","article-title":"Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015","volume":"19","author":"Zhang","year":"2015","journal-title":"Int. J. Tubercul. Lung Dis."},{"key":"10.1016\/j.micpath.2024.107116_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41579-019-0196-3","article-title":"Definitions and guidelines for research on antibiotic persistence","volume":"17","author":"Balaban","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00141-20","article-title":"Mechanisms of drug-induced tolerance in Mycobacterium tuberculosis","volume":"34","author":"Goossens","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2024.107116_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/mdr.2008.0772","article-title":"Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR","volume":"14","author":"Jiang","year":"2008","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.micpath.2024.107116_bib24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.meegid.2011.08.009","article-title":"Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex","volume":"12","author":"Rodrigues","year":"2012","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.micpath.2024.107116_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082235","article-title":"Association between HIV\/aids and multi-drug resistance tuberculosis: a systematic review and meta-analysis","volume":"9","author":"Mesfin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107116_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005561","article-title":"Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review","volume":"4","author":"Suchindran","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107116_bib27","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1111\/febs.15582","article-title":"Role of post-translational modifications in the acquisition of drug resistance in Mycobacterium tuberculosis","volume":"288","author":"Arora","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.micpath.2024.107116_bib28","first-page":"135","article-title":"Evaluation of post-translational modifications in histone proteins: a review on histone modification defects in developmental and neurological disorders","volume":"45","author":"Ramazi","year":"2020","journal-title":"J. Bio. Sci."},{"key":"10.1016\/j.micpath.2024.107116_bib29","doi-asserted-by":"crossref","first-page":"D344","DOI":"10.1093\/nar\/gks1067","article-title":"New and continuing developments at PROSITE","volume":"41","author":"Sigrist","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.micpath.2024.107116_bib30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.biochem.73.011303.074043","article-title":"Role of glycosylation in development","volume":"73","author":"Haltiwanger","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.micpath.2024.107116_bib31","first-page":"534","article-title":"Protein post-translational modifications and misfolding: new concepts in heart failure, PROTEOMICS \u2013 clin","volume":"8","author":"del Monte","year":"2014","journal-title":"Appl."},{"key":"10.1016\/j.micpath.2024.107116_bib32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.csbj.2017.03.004","article-title":"Protein post-translational modifications: In silico prediction tools and molecular modeling","volume":"15","author":"Audagnotto","year":"2017","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.micpath.2024.107116_bib33","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.bmc.2015.04.056","article-title":"Towards the computational design of protein post-translational regulation","volume":"23","author":"Strumillo","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.micpath.2024.107116_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mib.2010.02.003","article-title":"Two-component signal transduction","volume":"13","author":"Bourret","year":"2010","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbrc.2003.09.173","article-title":"Phosphoprotein phosphatase of Mycobacterium tuberculosis dephosphorylates serine\u2013threonine kinases PknA and PknB","volume":"311","author":"Chopra","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2024.107116_bib36","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1073\/pnas.0913482107","article-title":"Extensive phosphorylation with overlapping specificity by Mycobacterium tuberculosis serine\/threonine protein kinases","volume":"107","author":"Prisic","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micpath.2024.107116_bib37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1099\/mic.0.2007\/012153-0","article-title":"EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis","volume":"154","author":"Amin","year":"2008","journal-title":"Microbiology"},{"key":"10.1016\/j.micpath.2024.107116_bib38","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1111\/j.1742-4658.2006.05289.x","article-title":"EmbR, a regulatory protein with ATPase activity, is a substrate of multiple serine\/threonine kinases and phosphatase in Mycobacterium tuberculosis","volume":"273","author":"Sharma","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.micpath.2024.107116_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2958.2003.03809.x","article-title":"EthR, a repressor of the TetR\/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator","volume":"51","author":"Engohang-Ndong","year":"2004","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib40","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.bbrc.2014.03.074","article-title":"The Mycobacterium tuberculosis transcriptional repressor EthR is negatively regulated by Serine\/Threonine phosphorylation","volume":"446","author":"Leiba","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2024.107116_bib41","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jmb.2004.06.003","article-title":"Crystal structure of the TetR\/CamR family repressor Mycobacterium tuberculosis EthR implicated in ethionamide resistance","volume":"340","author":"Dover","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.micpath.2024.107116_bib42","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1128\/JB.05469-11","article-title":"Interaction of Mycobacterium tuberculosis elongation factor tu with GTP is regulated by phosphorylation","volume":"193","author":"Sajid","year":"2011","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2024.107116_bib43","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1021\/acs.jcim.1c01358","article-title":"Specificity and reactivity of Mycobacterium tuberculosis serine\/threonine kinases PknG and PknB","volume":"62","author":"Burastero","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.micpath.2024.107116_bib44","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1074\/mcp.RA118.000705","article-title":"Identification of novel physiological substrates of Mycobacterium bovis BCG protein kinase G (PknG) by label-free quantitative phosphoproteomics","volume":"17","author":"Nakedi","year":"2018","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.micpath.2024.107116_bib45","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1126\/science.1099384","article-title":"Protein kinase G from pathogenic mycobacteria promotes survival within macrophages","volume":"304","author":"Walburger","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.micpath.2024.107116_bib46","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1038\/srep02264","article-title":"Regulation of homocysteine metabolism by Mycobacterium tuberculosis S-adenosylhomocysteine hydrolase","volume":"3","author":"Singhal","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2024.107116_bib47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/CBB:33:2:101","article-title":"Structure and function of S-adenosylhomocysteine hydrolase","volume":"33","author":"Turner","year":"2000","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.micpath.2024.107116_bib48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/CMR.18.1.81-101.2005","article-title":"Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis","volume":"18","author":"Takayama","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2024.107116_bib49","series-title":"Mol. Genet. Mycobact.","first-page":"431","article-title":"Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: genes, mutations, and causalities","author":"Vilch\u00e8ze","year":"2014"},{"key":"10.1016\/j.micpath.2024.107116_bib50","doi-asserted-by":"crossref","first-page":"47029","DOI":"10.1074\/jbc.M108903200","article-title":"Purification and biochemical characterization of theMycobacterium tuberculosis \u03b2-Ketoacyl-acyl carrier protein synthases KasA and KasB","volume":"276","author":"Schaeffer","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2024.107116_bib51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1054\/tube.2002.0333","article-title":"The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis","volume":"82","author":"Slayden","year":"2002","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2024.107116_bib52","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.3390\/biomedicines10102592","article-title":"The role of phosphorylation and acylation in the regulation of drug resistance in Mycobacterium tuberculosis","volume":"10","author":"Sun","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.micpath.2024.107116_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005010","article-title":"Phosphorylation of the peptidoglycan synthase PonA1 governs the rate of polar elongation in mycobacteria","volume":"11","author":"Kieser","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2024.107116_bib54","first-page":"57","article-title":"Two faces of CwlM, an essential PknB substrate","volume":"vol. 25","author":"Turapov","year":"2018"},{"key":"10.1016\/j.micpath.2024.107116_bib55","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14590","article-title":"A cytoplasmic peptidoglycan amidase homologue controls mycobacterial cell wall synthesis","volume":"5","author":"Boutte","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.micpath.2024.107116_bib56","doi-asserted-by":"crossref","first-page":"16093","DOI":"10.1074\/jbc.M117.797563","article-title":"Protein kinase G confers survival advantage to Mycobacterium tuberculosis during latency-like conditions","volume":"292","author":"Khan","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2024.107116_bib57","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41392-022-01245-y","article-title":"Protein acylation: mechanisms, biological functions and therapeutic targets","volume":"7","author":"Shang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.micpath.2024.107116_bib58","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/mmi.13161","article-title":"Protein acetylation dynamics in response to carbon overflow in Escherichia coli","volume":"98","author":"Schilling","year":"2015","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.molcel.2013.06.003","article-title":"Acetyl-phosphate is a critical determinant of lysine acetylation in E. coli","volume":"51","author":"Weinert","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.micpath.2024.107116_bib60","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.celrep.2017.02.018","article-title":"Non-enzymatic N -acetylation of lysine residues by AcetylCoA often occurs via a proximal S -acetylated thiol intermediate sensitive to glyoxalase II","volume":"18","author":"James","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.micpath.2024.107116_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/science.1238858","article-title":"A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection","volume":"341","author":"Eskandarian","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.micpath.2024.107116_bib62","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/jac\/dks178","article-title":"The role of eis mutations in the development of kanamycin resistance in Mycobacterium tuberculosis isolates from the Moscow region","volume":"67","author":"Gikalo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aao1478","article-title":"Posttranslational modification of a histone-like protein regulates phenotypic resistance to isoniazid in mycobacteria","volume":"4","author":"Sakatos","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.micpath.2024.107116_bib64","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1021\/acs.jproteome.7b00429","article-title":"N\u03b5- and O-acetylation in Mycobacterium tuberculosis lineage 7 and lineage 4 strains: proteins involved in bioenergetics, virulence, and antimicrobial resistance are acetylated","volume":"16","author":"Birhanu","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.micpath.2024.107116_bib65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0971-5916.154492","article-title":"Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant","volume":"141","author":"Singh","year":"2015","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.micpath.2024.107116_bib66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/mmi.13535","article-title":"Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria","volume":"103","author":"Singh","year":"2017","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib67","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3390\/vaccines8040773","article-title":"Understanding GroEL and DnaK stress response proteins as antigens for bacterial diseases","volume":"8","author":"Fourie","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.micpath.2024.107116_bib68","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00284-012-0104-9","article-title":"Genome-wide expression profiling of the response to linezolid in Mycobacterium tuberculosis","volume":"64","author":"Liang","year":"2012","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib69","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1016\/j.febslet.2006.11.042","article-title":"Cyclosporin A binding to Mycobacterium tuberculosis peptidyl-prolyl cis\u2013trans isomerase A \u2013 Investigation by CD, FTIR and fluorescence spectroscopy","volume":"580","author":"Mitra","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.micpath.2024.107116_bib70","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1021\/pr500859a","article-title":"First succinyl-proteome profiling of extensively drug-resistant Mycobacterium tuberculosis revealed involvement of succinylation in cellular physiology","volume":"14","author":"Xie","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.micpath.2024.107116_bib71","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.gendis.2022.03.009","article-title":"Protein post-translational modification by lysine succinylation: biochemistry, biological implications, and therapeutic opportunities","volume":"10","author":"Zhao","year":"2023","journal-title":"Genes Dis"},{"key":"10.1016\/j.micpath.2024.107116_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tube.2019.01.001","article-title":"Mycobacteria and their sweet proteins: an overview of protein glycosylation and lipoglycosylation in M. tuberculosis","volume":"115","author":"Mehaffy","year":"2019","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2024.107116_bib73","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1073\/pnas.1219704110","article-title":"Bacterial protein-O-mannosylating enzyme is crucial for virulence of Mycobacterium tuberculosis","volume":"110","author":"Liu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micpath.2024.107116_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02123","article-title":"Lipoprotein glycosylation by protein-O-mannosyltransferase (MAB_1122c) contributes to low cell envelope permeability and antibiotic resistance of Mycobacterium abscessus","volume":"8","author":"Becker","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib75","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/nar\/gkac1173","article-title":"SigH stress response mediates killing of Mycobacterium tuberculosis by activating nitronaphthofuran prodrugs via induction of Mrx2 expression","volume":"51","author":"Cioetto-Mazzab\u00f2","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.micpath.2024.107116_bib76","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1038\/s41598-019-39654-9","article-title":"Ample glycosylation in membrane and cell envelope proteins may explain the phenotypic diversity and virulence in the Mycobacterium tuberculosis complex","volume":"9","author":"Birhanu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2024.107116_bib77","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1128\/AAC.00647-09","article-title":"Lipoprotein processing is essential for resistance of Mycobacterium tuberculosis to malachite green","volume":"53","author":"Banaei","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib78","series-title":"Mol. Genet. Mycobact.","first-page":"667","article-title":"The pup-proteasome system of mycobacteria","author":"Bode","year":"2014"},{"key":"10.1016\/j.micpath.2024.107116_bib79","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1741-7007-10-95","article-title":"The pupylation pathway and its role in mycobacteria","volume":"10","author":"Barandun","year":"2012","journal-title":"BMC Biol."},{"key":"10.1016\/j.micpath.2024.107116_bib80","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1128\/JB.01597-06","article-title":"Characterization of the proteasome accessory factor (paf) operon in Mycobacterium tuberculosis","volume":"189","author":"Festa","year":"2007","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2024.107116_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181221","article-title":"Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages","volume":"12","author":"Idh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107116_bib82","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1128\/AAC.48.8.3006-3009.2004","article-title":"Nitric oxide generated from isoniazid activation by KatG: source of nitric oxide and activity against Mycobacterium tuberculosis, antimicrob","volume":"48","author":"Timmins","year":"2004","journal-title":"Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib83","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1462-5822.2003.00307.x","article-title":"The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis","volume":"5","author":"Ohno","year":"2003","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib84","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.06227-11","article-title":"rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains","volume":"56","author":"Beckert","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib85","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.01541-12","article-title":"Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission","volume":"57","author":"de Vos","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib86","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/msb.2010.39","article-title":"Proteome-wide identification of mycobacterial pupylation targets","volume":"6","author":"Poulsen","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.micpath.2024.107116_bib87","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00018-012-1096-0","article-title":"Structure and function of biotin-dependent carboxylases","volume":"70","author":"Tong","year":"2013","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.micpath.2024.107116_bib88","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.chembiol.2011.08.013","article-title":"Bisubstrate adenylation inhibitors of biotin protein ligase from Mycobacterium tuberculosis","volume":"18","author":"Duckworth","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.micpath.2024.107116_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002320","article-title":"Ligand specificity of group I biotin protein ligase of Mycobacterium tuberculosis","volume":"3","author":"Purushothaman","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107116_bib90","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal1803","article-title":"Targeting protein biotinylation enhances tuberculosis chemotherapy","volume":"10","author":"Tiwari","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.micpath.2024.107116_bib91","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1039\/C3NP70054B","article-title":"The phosphopantetheinyl transferases: catalysis of a post-translational modification crucial for life","volume":"31","author":"Beld","year":"2014","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.micpath.2024.107116_bib92","doi-asserted-by":"crossref","first-page":"37289","DOI":"10.1074\/jbc.M103556200","article-title":"4\u2032-Phosphopantetheine transfer in primary and secondary metabolism of Bacillus subtilis","volume":"276","author":"Mootz","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2024.107116_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003097","article-title":"4\u2032-Phosphopantetheinyl transferase PptT, a new drug target required for Mycobacterium tuberculosis growth and persistence in vivo","volume":"8","author":"Leblanc","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2024.107116_bib94","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.chembiol.2009.04.001","article-title":"Mycolic acid cyclopropanation is essential for viability, drug resistance, and cell wall integrity of Mycobacterium tuberculosis","volume":"16","author":"Barkan","year":"2009","journal-title":"Chem. Biol."},{"key":"10.1016\/j.micpath.2024.107116_bib95","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau8959","article-title":"Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition","volume":"363","author":"Ballinger","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.micpath.2024.107116_bib96","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrg3173","article-title":"Histone methylation: a dynamic mark in health, disease and inheritance","volume":"13","author":"Greer","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.micpath.2024.107116_bib97","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1128\/AAC.00264-06","article-title":"Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible","volume":"50","author":"Andini","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib98","doi-asserted-by":"crossref","first-page":"38942","DOI":"10.1074\/jbc.M505727200","article-title":"Methyltransferase erm(37) slips on rRNA to confer atypical resistance in Mycobacterium tuberculosis","volume":"280","author":"Madsen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2024.107116_bib99","doi-asserted-by":"crossref","first-page":"8922","DOI":"10.1038\/ncomms9922","article-title":"Mycobacteria modulate host epigenetic machinery by Rv1988 methylation of a non-tail arginine of histone H3","volume":"6","author":"Yaseen","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2024.107116_bib100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13073-015-0164-0","article-title":"Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences","volume":"7","author":"Coll","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.micpath.2024.107116_bib101","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2105-15-107","article-title":"MUBII-TB-DB: a database of mutations associated with antibiotic resistance in Mycobacterium tuberculosis","volume":"15","author":"Flandrois","year":"2014","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.micpath.2024.107116_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000002","article-title":"Tuberculosis drug resistance mutation database","volume":"6","author":"Sandgren","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.micpath.2024.107116_bib103","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1080\/22221751.2020.1785334","article-title":"Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis","volume":"9","author":"Swain","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.micpath.2024.107116_bib104","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/antibiotics3030317","article-title":"Drug resistance mechanisms in Mycobacterium tuberculosis","volume":"3","author":"Palomino","year":"2014","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2024.107116_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119628","article-title":"Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review","volume":"10","author":"Seifert","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107116_bib106","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/03602532.2018.1533966","article-title":"Mechanistic investigation of resistance via drug-inactivating enzymes in Mycobacterium tuberculosis","volume":"50","author":"Kashyap","year":"2018","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.micpath.2024.107116_bib107","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.1038\/s41598-020-65766-8","article-title":"Survey of drug resistance associated gene mutations in Mycobacterium tuberculosis, ESKAPE and other bacterial species","volume":"10","author":"Ghosh","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2024.107116_bib108","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1080\/22221751.2020.1774425","article-title":"Emergence of multidrug-resistant Mycobacterium tuberculosis of the Beijing lineage in Portugal and Guinea-Bissau: a snapshot of moving clones by whole-genome sequencing","volume":"9","author":"Perdig\u00e3o","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.micpath.2024.107116_bib109","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/AAC.00112-06","article-title":"Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant","volume":"50","author":"Hazb\u00f3n","year":"2006","journal-title":"Mycobacterium tuberculosis, Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2180-9-39","article-title":"Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosisclinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America","volume":"9","author":"Dalla Costa","year":"2009","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib111","doi-asserted-by":"crossref","first-page":"7596","DOI":"10.1128\/JB.187.22.7596-7606.2005","article-title":"Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis","volume":"187","author":"Bhatt","year":"2005","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2024.107116_bib112","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0014-2013","article-title":"Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: genes, mutations, and causalities","volume":"2","author":"Vilch\u00e8ze","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.micpath.2024.107116_bib113","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/IDR.S346869","article-title":"The regulation of ManLAM-related gene expression in Mycobacterium tuberculosis with different drug resistance profiles following isoniazid Treatment&lt","volume":"15","author":"Yimcharoen","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2024.107116_bib114","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00907-19","article-title":"Automatic identification of individual rpoB gene mutations responsible for rifampin resistance in Mycobacterium tuberculosis by use of melting temperature signatures generated by the xpert MTB\/RIF ultra assay","volume":"58","author":"Cao","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.tube.2018.08.010","article-title":"Integrated analysis of ethionamide resistance loci in Mycobacterium tuberculosis clinical isolates","volume":"113","author":"da Silva","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2024.107116_bib116","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5185896","article-title":"Mutations associated with rifampicin resistance in Mycobacterium tuberculosis isolates from Moroccan patients: systematic review","volume":"2020","author":"Eddabra","year":"2020","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"key":"10.1016\/j.micpath.2024.107116_bib117","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1128\/AAC.01030-10","article-title":"Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis","volume":"55","author":"Brossier","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib118","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12879-019-3764-2","article-title":"Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan","volume":"19","author":"khan","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2024.107116_bib119","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/JCM.01903-13","article-title":"Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China","volume":"52","author":"Tan","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.gene.2016.01.024","article-title":"Molecular principles behind pyrazinamide resistance due to mutations in panD gene in Mycobacterium tuberculosis","volume":"581","author":"Pandey","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.micpath.2024.107116_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003994","article-title":"Post-translational regulation via Clp Protease is critical for survival of Mycobacterium tuberculosis","volume":"10","author":"Raju","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2024.107116_bib122","first-page":"2713","article-title":"The roles of rpsL, rrs, and gidB mutations in predicting streptomycin-resistant drugs used on clinical Mycobacterium tuberculosis isolates from Hebei Province, China","volume":"12","author":"Wang","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.micpath.2024.107116_bib123","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/AAC.01814-10","article-title":"Mutations in gidB confer low-level streptomycin resistance in Mycobacterium tuberculosis, Antimicrob","volume":"55","author":"Wong","year":"2011","journal-title":"Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib124","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1093\/jac\/dku273","article-title":"Evaluation of gidB alterations responsible for streptomycin resistance in Mycobacterium tuberculosis","volume":"69","author":"Verma","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120470","article-title":"Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review","volume":"10","author":"Avalos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107116_bib126","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.micpath.2024.107116_bib127","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/AAC.00244-06","article-title":"Genetic basis for natural and acquired resistance to the diarylquinoline R207910 in mycobacteria","volume":"50","author":"Petrella","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102135","article-title":"Acquired resistance of Mycobacterium tuberculosis to bedaquiline","volume":"9","author":"Andries","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107116_bib129","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.00037-14","article-title":"Cross-resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosis, Antimicrob","volume":"58","author":"Hartkoorn","year":"2014","journal-title":"Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib130","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1128\/AAC.00753-16","article-title":"Mutations in pepQ confer low-level resistance to bedaquiline and clofazimine in Mycobacterium tuberculosis, Antimicrob","volume":"60","author":"Almeida","year":"2016","journal-title":"Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib131","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jac\/dkx506","article-title":"Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care","volume":"73","author":"Dookie","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib132","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1093\/cid\/ciaa755","article-title":"Delamanid resistance: update and clinical management","volume":"71","author":"Nguyen","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2024.107116_bib133","first-page":"186","article-title":"Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis, Tuberc","volume":"108","author":"Fujiwara","year":"2018","journal-title":"Edinb. Scotl."},{"key":"10.1016\/j.micpath.2024.107116_bib134","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/cid\/ciz074","article-title":"Emergence of low-level delamanid and bedaquiline resistance during extremely drug-resistant tuberculosis treatment","volume":"69","author":"Polsfuss","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2024.107116_bib135","doi-asserted-by":"crossref","unstructured":"Mutations in fbiD (Rv2983) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis, (n.d.). https:\/\/doi.org\/10.1128\/aac.01948-20.","DOI":"10.1128\/AAC.01948-20"},{"key":"10.1016\/j.micpath.2024.107116_bib136","unstructured":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, (n.d.). https:\/\/www.who.int\/publications\/i\/item\/9789240028173 (accessed October 9, 2024)."},{"key":"10.1016\/j.micpath.2024.107116_bib137","first-page":"4119","article-title":"rpoB mutations and effects on rifampin resistance in Mycobacterium tuberculosis, infect","volume":"14","author":"Li","year":"2021","journal-title":"Drug Res."},{"key":"10.1016\/j.micpath.2024.107116_bib138","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/catal10050543","article-title":"Insights into the mechanism of ethionamide resistance in Mycobacterium tuberculosis through an in silico structural evaluation of EthA and mutants identified in clinical isolates","volume":"10","author":"de Souza","year":"2020","journal-title":"Catalysts"},{"key":"10.1016\/j.micpath.2024.107116_bib139","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajic.2006.05.219","article-title":"Mechanisms of antimicrobial resistance in bacteria","volume":"34","author":"Tenover","year":"2006","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.micpath.2024.107116_bib140","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1128\/AAC.47.12.3799-3805.2003","article-title":"ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates, antimicrob","volume":"47","author":"Morlock","year":"2003","journal-title":"Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib141","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41598-020-58635-x","article-title":"Structure guided prediction of Pyrazinamide resistance mutations in pncA","volume":"10","author":"Karmakar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2024.107116_bib142","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.2147\/IDR.S260161","article-title":"Pyrazinamide resistance and mutation patterns among multidrug-resistant Mycobacterium tuberculosis from henan Province&lt","volume":"13","author":"Shi","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2024.107116_bib143","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1208813","article-title":"Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis","volume":"333","author":"Shi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.micpath.2024.107116_bib144","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02342-16","article-title":"Missense mutations in the unfoldase ClpC1 of the caseinolytic protease complex are associated with pyrazinamide resistance in Mycobacterium tuberculosis, antimicrob","volume":"61","author":"Yee","year":"2017","journal-title":"Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib145","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/acschembio.1c00131","article-title":"Mycobacterium tuberculosis PanD structure\u2013function analysis and identification of a potent pyrazinoic acid-derived enzyme inhibitor","volume":"16","author":"Ragunathan","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.micpath.2024.107116_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2014.61","article-title":"Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis","volume":"3","author":"Shi","year":"2014","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.micpath.2024.107116_bib147","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12890-020-1172-4","article-title":"Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients","volume":"20","author":"Kabir","year":"2020","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.micpath.2024.107116_bib148","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/cid\/cix992","article-title":"Bedaquiline resistance: its emergence, mechanism, and prevention","volume":"66","author":"Nguyen","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2024.107116_bib149","article-title":"Nanotechnology-based approach in tuberculosis treatment","volume":"2017","author":"Nasiruddin","year":"2017","journal-title":"Tuberc. Res. Treat."},{"key":"10.1016\/j.micpath.2024.107116_bib150","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00284-012-0215-3","article-title":"The expression of ABC efflux pump, Rv1217c-Rv1218c, and its association with multidrug resistance of Mycobacterium tuberculosis in China","volume":"66","author":"Wang","year":"2013","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib151","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00204-016-1727-6","article-title":"Antibiotic resistance mechanisms in M. tuberculosis: an update","volume":"90","author":"Nguyen","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.micpath.2024.107116_bib152","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.3389\/fmicb.2018.03072","article-title":"Insights on Mycobacterium leprae efflux pumps and their implications in drug resistance and virulence","volume":"9","author":"Machado","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib153","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41586-020-2072-8","article-title":"A mycobacterial ABC transporter mediates the uptake of hydrophilic compounds","volume":"580","author":"Rempel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2024.107116_bib154","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13756-019-0516-4","article-title":"Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant Mycobacterium tuberculosis: mutations versus efflux pumps","volume":"8","author":"Ghajavand","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.micpath.2024.107116_bib155","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00232-017-9982-x","article-title":"Mycobacterium tuberculosis major facilitator superfamily transporters","volume":"250","author":"Li","year":"2017","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.micpath.2024.107116_bib156","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fcimb.2018.00114","article-title":"Molecular targets related drug resistance mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis strains","volume":"8","author":"Hameed","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib157","article-title":"Mutations in efflux pump Rv1258c (Tap) cause resistance to pyrazinamide, isoniazid, and streptomycin in M. tuberculosis","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib158","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/ijmy.ijmy_26_17","article-title":"Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of Mycobacterium tuberculosis","volume":"6","author":"Narang","year":"2017","journal-title":"Int. J. Mycobacteriology"},{"key":"10.1016\/j.micpath.2024.107116_bib159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-695X.2011.00831.x","article-title":"Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis","volume":"63","author":"da Silva","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib160","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1128\/AAC.01482-12","article-title":"Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis, Antimicrob","volume":"57","author":"Rodrigues","year":"2013","journal-title":"Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib161","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/ijmr.IJMR_2079_17","article-title":"Efflux pump inhibitors for bacterial pathogens: from bench to bedside","volume":"149","author":"Sharma","year":"2019","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.micpath.2024.107116_bib162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008101","article-title":"Identification of binding residues between periplasmic adapter protein (PAP) and RND efflux pumps explains PAP-pump promiscuity and roles in antimicrobial resistance","volume":"15","author":"McNeil","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2024.107116_bib163","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tube.2017.08.001","article-title":"MmpS5\/MmpL5 as an efflux pump in Mycobacterium species","volume":"107","author":"Briffotaux","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2024.107116_bib164","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3389\/fmicb.2017.00681","article-title":"New insights in to the intrinsic and acquired drug resistance mechanisms in mycobacteria","volume":"8","author":"Nasiri","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib165","first-page":"53","article-title":"Molecular biology of drug resistance in Mycobacterium tuberculosis, Curr","volume":"374","author":"Smith","year":"2013","journal-title":"Top. Microbiol. Immunol."},{"key":"10.1016\/j.micpath.2024.107116_bib166","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/femsre\/fux011","article-title":"Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives","volume":"41","author":"Gygli","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.micpath.2024.107116_bib167","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mib.2017.11.020","article-title":"Lipid metabolism and its implication in mycobacteria-host interaction","volume":"41","author":"Gago","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib168","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010406","article-title":"MurA escape mutations uncouple peptidoglycan biosynthesis from PrkA signaling","volume":"18","author":"Wamp","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2024.107116_bib169","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3201\/eid2311.171130","article-title":"High-level Fosfomycin resistance in vancomycin-resistant Enterococcus faecium","volume":"23","author":"Guo","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.micpath.2024.107116_bib170","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1590\/S0100-72032009001100001","article-title":"Infections by rapidly growing mycobacteria resistant to disinfectants: a national matter?","volume":"31","author":"Pitombo","year":"2009","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"10.1016\/j.micpath.2024.107116_bib171","first-page":"210","article-title":"Nontuberculous mycobacterial pulmonary infections","volume":"6","author":"Johnson","year":"2014","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.micpath.2024.107116_bib172","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.3389\/fimmu.2019.02909","article-title":"Underestimated manipulative roles of Mycobacterium tuberculosis cell envelope glycolipids during infection","volume":"10","author":"Garcia-Vilanova","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2024.107116_bib173","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000226425","article-title":"Differences in cell wall thickness between resistant and nonresistant strains of Mycobacterium tuberculosis: using transmission electron microscopy","volume":"55","author":"Velayati","year":"2009","journal-title":"Chemotherapy"},{"key":"10.1016\/j.micpath.2024.107116_bib174","first-page":"193","article-title":"Sequential adaptation in latent tuberculosis bacilli: observation by atomic force microscopy (AFM)","volume":"4","author":"Velayati","year":"2011","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.micpath.2024.107116_bib175","unstructured":"The End TB Strategy, (n.d.). https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/the-end-tb-strategy (accessed May 16, 2024)."},{"key":"10.1016\/j.micpath.2024.107116_bib176","series-title":"Plant-Deriv. Nat. Prod. Synth. Funct. Appl.","first-page":"3","article-title":"Introduction to the different classes of natural products","author":"Springob","year":"2009"},{"key":"10.1016\/j.micpath.2024.107116_bib177","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.micres.2016.12.003","article-title":"Phytochemicals for human disease: an update on plant-derived compounds antibacterial activity","volume":"196","author":"Barbieri","year":"2017","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.micpath.2024.107116_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104203","article-title":"Exploring how structural changes to new Licarin A derivatives effects their bioactive properties against rapid growing mycobacteria and biofilm formation","volume":"144","author":"Alvarenga","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2024.107116_bib179","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1590\/S0074-02762010000100006","article-title":"Antimycobacterial neolignans isolated from Aristolochia taliscana","volume":"105","author":"Le\u00f3n-D\u00edaz","year":"2010","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.micpath.2024.107116_bib180","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.3390\/molecules16097357","article-title":"Antibacterial activity of Aristolochia brevipes against multidrug-resistant Mycobacterium tuberculosis","volume":"16","author":"Navarro-Garc\u00eda","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2024.107116_bib181","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061925","article-title":"Inhibition of nuclear factor-kappa B activation decreases survival of Mycobacterium tuberculosis in human macrophages","volume":"8","author":"Bai","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107116_bib182","article-title":"Antiprotozoal and antimycobacterial activities of pure compounds from Aristolochia elegans rhizomes, evid.-based complement","volume":"2012","author":"Jim\u00e9nez-Arellanes","year":"2012","journal-title":"Altern. Med. ECAM"},{"key":"10.1016\/j.micpath.2024.107116_bib183","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jiac.2015.11.014","article-title":"Antimycobacterial activity of methanolic plant extract of Artemisia capillaris containing ursolic acid and hydroquinone against Mycobacterium tuberculosis","volume":"22","author":"Jyoti","year":"2016","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib184","article-title":"Ursolic acid reduces Mycobacterium tuberculosis-induced nitric oxide release in human alveolar A549 cells","volume":"38","author":"Zerin","year":"2015","journal-title":"Mol. Cell."},{"key":"10.1016\/j.micpath.2024.107116_bib185","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1472-6882-13-258","article-title":"Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment","volume":"13","author":"Jim\u00e9nez-Arellanes","year":"2013","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.micpath.2024.107116_bib186","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.2147\/DDDT.S454399","article-title":"Promising ursolic acid as a novel antituberculosis agent: current progress and challenges","volume":"18","author":"Pitaloka","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.micpath.2024.107116_bib187","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.bjp.2019.06.001","article-title":"In vitro growth inhibition and bactericidal activity of spathulenol against drug-resistant clinical isolates of Mycobacterium tuberculosis","volume":"29","author":"Dzul-Beh","year":"2019","journal-title":"Rev. Bras. Farmacogn."},{"key":"10.1016\/j.micpath.2024.107116_bib188","article-title":"Biological activity and traditional use of the phytocompounds from Azorella compacta","author":"Mascitti","year":"2020","journal-title":"Phill, 1891)"},{"key":"10.1016\/j.micpath.2024.107116_bib189","article-title":"Anti-mycobacterial and immunomodulatory activity of n-hexane fraction and spathulenol from Ocotea notata leaves","volume":"72","author":"de J B Costa","year":"2021","journal-title":"Rodriguesia"},{"key":"10.1016\/j.micpath.2024.107116_bib190","doi-asserted-by":"crossref","first-page":"16430","DOI":"10.3390\/ijms131216430","article-title":"Secondary metabolites from the roots of beilschmiedia tsangii and their anti-inflammatory activities","volume":"13","author":"Huang","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2024.107116_bib191","first-page":"46","article-title":"The role of nitric oxide in mycobacterial infections","volume":"9","author":"Yang","year":"2009","journal-title":"Immune Netw. Off. J. Korean Soc. Immunol. Biol. Response Modif."},{"key":"10.1016\/j.micpath.2024.107116_bib192","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-2008-1034330","article-title":"Anti-infective and cytotoxic compounds present in Blepharodon nitidum","volume":"74","author":"Aponte","year":"2008","journal-title":"Planta Med."},{"key":"10.1016\/j.micpath.2024.107116_bib193","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.bmc.2011.02.034","article-title":"Dihydro-\u03b2-agarofuran sesquiterpenes isolated from Celastrus vulcanicola as potential anti-Mycobacterium tuberculosis multidrug-resistant agents","volume":"19","author":"Torres-Romero","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.micpath.2024.107116_bib194","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jep.2013.06.022","article-title":"Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates","volume":"149","author":"Mehta","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.micpath.2024.107116_bib195","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2174\/1570180817999200514102750","article-title":"Molecular insights into the interaction of ursolic acid and cucurbitacin from colocynth with therapeutic targets of Mycobacterium tuberculosis","volume":"17","author":"Ali","year":"2020","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.micpath.2024.107116_bib196","doi-asserted-by":"crossref","first-page":"28201","DOI":"10.1074\/jbc.M003241200","article-title":"Identification and substrate specificity of \u03b2-ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis","volume":"275","author":"Choi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2024.107116_bib197","doi-asserted-by":"crossref","first-page":"51494","DOI":"10.1074\/jbc.M308638200","article-title":"Beta-ketoacyl-acyl carrier protein synthase III (FabH) is essential for bacterial fatty acid synthesis","volume":"278","author":"Lai","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2024.107116_bib198","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3390\/biom11091278","article-title":"Therapeutic potential of curcumin as an antimycobacterial agent","volume":"11","author":"Barua","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.micpath.2024.107116_bib199","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1016\/j.ejmech.2010.07.003","article-title":"Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity","volume":"45","author":"Changtam","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.micpath.2024.107116_bib200","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1087057106296484","article-title":"A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase","volume":"12","author":"White","year":"2007","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.micpath.2024.107116_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2018.12.008","article-title":"Allicin enhances antimicrobial activity of macrophages during Mycobacterium tuberculosis infection","volume":"243","author":"Dwivedi","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.micpath.2024.107116_bib202","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0005-2736(99)00174-1","article-title":"The mode of action of allicin: its ready permeability through phospholipid membranes may contribute to its biological activity","volume":"1463","author":"Miron","year":"2000","journal-title":"Biochim. Biophys. Acta BBA - Biomembr."},{"key":"10.1016\/j.micpath.2024.107116_bib203","doi-asserted-by":"crossref","first-page":"474","DOI":"10.51248\/.v40i4.322","article-title":"Target related in silico analysis of Bergenin and tuberculosis management","volume":"40","author":"Bastikar","year":"2021","journal-title":"Biomedicine"},{"key":"10.1016\/j.micpath.2024.107116_bib204","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.tube.2014.04.007","article-title":"Protective efficacy of piperine against Mycobacterium tuberculosis","volume":"94","author":"Sharma","year":"2014","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2024.107116_bib205","article-title":"Anti-mycobacterial activity of Piper longum L. fruit extracts against multi drug resistant Mycobacterium Spp","author":"Singh","year":"2011","journal-title":"Int. J. Phytomed."},{"key":"10.1016\/j.micpath.2024.107116_bib206","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jac\/dkq186","article-title":"Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis","volume":"65","author":"Sharma","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2024.107116_bib207","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12879-015-0905-0","article-title":"Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates","volume":"15","author":"Zhang","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2024.107116_bib208","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jfma.2012.03.009","article-title":"Inhibition of the Mycobacterium tuberculosis reserpine-sensitive efflux pump augments intracellular concentrations of ciprofloxacin and enhances susceptibility of some clinical isolates","volume":"112","author":"Huang","year":"2013","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.micpath.2024.107116_bib209","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2017.00149","article-title":"The phytochemical bergenin enhances T helper 1 responses and anti-mycobacterial immunity by activating the MAP kinase pathway in macrophages","volume":"7","author":"Dwivedi","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12906-017-1786-0","article-title":"Thymoquinone (TQ) inhibits the replication of intracellular Mycobacterium tuberculosis in macrophages and modulates nitric oxide production","volume":"17","author":"Mahmud","year":"2017","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.micpath.2024.107116_bib211","author":"Khamjan"},{"key":"10.1016\/j.micpath.2024.107116_bib212","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.biocel.2005.10.021","article-title":"Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages","volume":"38","author":"Anand","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.micpath.2024.107116_bib213","doi-asserted-by":"crossref","DOI":"10.1177\/11779322241257039","article-title":"Targeting decaprenylphosphoryl-\u03b2-D-ribose 2\u2032-epimerase for innovative drug development against Mycobacterium tuberculosis drug-resistant strains","volume":"18","author":"El Haddoumi","year":"2024","journal-title":"Bioinf. Biol. Insights"},{"key":"10.1016\/j.micpath.2024.107116_bib214","first-page":"31","article-title":"Unveiling naturally occurring green tea polyphenol epigallocatechin-3-gallate (EGCG) targeting Mycobacterium DPRE1 for anti-Tb drug discovery","volume":"11","author":"Mali","year":"2021","journal-title":"Eng. Proc."},{"key":"10.1016\/j.micpath.2024.107116_bib215","author":"E"},{"key":"10.1016\/j.micpath.2024.107116_bib216","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijbiomac.2015.04.005","article-title":"Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus","volume":"78","author":"Shukla","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2024.107116_bib217","doi-asserted-by":"crossref","first-page":"10423","DOI":"10.1002\/chem.201701812","article-title":"Natural and synthetic flavonoids as potent Mycobacterium tuberculosis UGM inhibitors","volume":"23","author":"Villaume","year":"2017","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.micpath.2024.107116_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.103971","article-title":"Sophoradiol inhibits the growth of drug resistant Mycobacterium tuberculosis in vitro and murine models of tuberculosis","volume":"141","author":"Lu","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2024.107116_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.101987","article-title":"Three promising antimycobacterial medicinal plants reviewed as potential sources of drug hit candidates against multidrug-resistant tuberculosis","volume":"124","author":"Tuyiringire","year":"2020","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2024.107116_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115973","article-title":"A comprehensive review on the biological interest of quinoline and its derivatives","volume":"32","author":"Matada","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.micpath.2024.107116_bib221","first-page":"10","article-title":"Anti-mycobacterial efficacy of three essentials oils from medicinal plants currently used traditionally to treat tuberculosis in Cameroon","volume":"6","author":"Ndedi","year":"2018","journal-title":"Am. J. Essent. Oils Nat. Prod."},{"key":"10.1016\/j.micpath.2024.107116_bib222","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jep.2010.04.033","article-title":"Inhibitory properties of selected South African medicinal plants against Mycobacterium tuberculosis","volume":"130","author":"Green","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.micpath.2024.107116_bib223","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1128\/AEM.01967-13","article-title":"Insights into the mode of action of Benzyl isothiocyanate on Campylobacter jejuni","volume":"79","author":"Dufour","year":"2013","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.micpath.2024.107116_bib224","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijantimicag.2013.02.011","article-title":"A role for 16S rRNA dimethyltransferase (ksgA) in intrinsic clarithromycin resistance in Mycobacterium tuberculosis","volume":"41","author":"Phunpruch","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2024.107116_bib225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/scipharm85010014","article-title":"Combination effect of antituberculosis drugs and ethanolic extract of selected medicinal plants against multi-drug resistant Mycobacterium tuberculosis isolates","volume":"85","author":"Fauziyah","year":"2017","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.micpath.2024.107116_bib226","first-page":"565","article-title":"Antimycobacterial activity of two natural alkaloids, vasicine acetate and 2-acetyl benzylamine, isolated from Indian shrub Adhatoda vasica Ness. leaves","volume":"35","author":"Ignacimuthu","year":"2010","journal-title":"J. Bio. Sci."},{"key":"10.1016\/j.micpath.2024.107116_bib227","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/1386207319666151203001708","article-title":"An in silico approach for identification of potential anti-mycobacterial targets of vasicine and related chemical compounds","volume":"19","author":"Kashyap Chaliha","year":"2016","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.micpath.2024.107116_bib228","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/IAI.68.2.767-778.2000","article-title":"Disruption of the genes encoding antigen 85A and antigen 85B ofMycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages","volume":"68","author":"Armitige","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2024.107116_bib229","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijtb.2019.11.015","article-title":"Prevalence of p-glycoprotein (PGP) expression, function and its effect on efficacy of rifampicin in patients with lymph node tuberculosis","volume":"67","author":"Nath","year":"2020","journal-title":"Indian J. Tubercul."},{"key":"10.1016\/j.micpath.2024.107116_bib230","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.canlet.2013.07.017","article-title":"Silibinin reverses drug resistance in human small-cell lung carcinoma cells","volume":"339","author":"Sadava","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.micpath.2024.107116_bib231","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217457","article-title":"A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: in vitro and in vivo studies","volume":"14","author":"Rodr\u00edguez-Flores","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107116_bib232","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.bmcl.2012.02.053","article-title":"Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis","volume":"22","author":"Sureram","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.micpath.2024.107116_bib233","article-title":"Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107116_bib234","volume":"1","author":"Garg","year":"2013","journal-title":"Clinical Use of Andrographolide as a Potential Drug against Vole Tuberculosis"},{"key":"10.1016\/j.micpath.2024.107116_bib235","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jmgm.2015.07.001","article-title":"Andrographolide: a potent antituberculosis compound that targets Aminoglycoside 2\u2019-N-acetyltransferase in Mycobacterium tuberculosis","volume":"61","author":"Prabu","year":"2015","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.micpath.2024.107116_bib236","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/0970-2113.217567","article-title":"Effect of efflux pump inhibitors on the susceptibility of Mycobacterium tuberculosis to isoniazid","volume":"34","author":"Jaiswal","year":"2017","journal-title":"Lung India Off. Organ Indian Chest Soc"},{"key":"10.1016\/j.micpath.2024.107116_bib237","first-page":"809","article-title":"Anti-tuberculosis activity of selected medicinal plants against multi-drug resistant Mycobacterium tuberculosis isolates","volume":"131","author":"Gupta","year":"2010","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.micpath.2024.107116_bib238","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s13205-018-1450-5","article-title":"Antimycobacterial potentials of quercetin and rutin against Mycobacterium tuberculosis H37Rv","volume":"8","author":"Sasikumar","year":"2018","journal-title":"3 Biotech"},{"key":"10.1016\/j.micpath.2024.107116_bib239","article-title":"Cytotoxic potential of andrographolide against bovine tuberculosis","volume":"8","author":"Shrivastava","year":"2013","journal-title":"IOSR J. Pharm. Biol. Sci."},{"key":"10.1016\/j.micpath.2024.107116_bib240","series-title":"Carbohydr. Polym. - CARBOHYD POLYM","first-page":"210","article-title":"Plants: diet and health: the report of a British nutrition foundation task force","author":"Saltmarsh","year":"2008"},{"key":"10.1016\/j.micpath.2024.107116_bib241","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1074\/jbc.RA119.008005","article-title":"The phytochemical bergenin as an adjunct immunotherapy for tuberculosis in mice","volume":"294","author":"Kumar","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2024.107116_bib242","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1753425917747975","article-title":"Enhancement of the antimycobacterial activity of macrophages by ajoene","volume":"24","author":"Choi","year":"2018","journal-title":"Innate Immun."},{"key":"10.1016\/j.micpath.2024.107116_bib243","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3389\/fimmu.2017.00739","article-title":"Nanoparticle-formulated curcumin prevents posttherapeutic disease reactivation and reinfection with Mycobacterium tuberculosis following isoniazid therapy","volume":"8","author":"Tousif","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2024.107116_bib244","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106809","article-title":"[6]-Gingerol exhibits potent anti-mycobacterial and immunomodulatory activity against tuberculosis","volume":"87","author":"Bhaskar","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.micpath.2024.107116_bib245","article-title":"How does curcumin work with poor bioavailability? Clues from experimental and theoretical studies","volume":"6","author":"Shen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2024.107116_bib246","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.phytochem.2016.02.005","article-title":"Tetrandrine--A molecule of wide bioactivity","volume":"125","author":"Bhagya","year":"2016","journal-title":"Phytochemistry"},{"key":"10.1016\/j.micpath.2024.107116_bib247","first-page":"48","article-title":"A randomized, controlled, phase III clinical trial to evaluate the efficacy and tolerability of risorine with conventional rifampicin in the treatment of newly diagnosed pulmonary tuberculosis patients","volume":"65","author":"Patel","year":"2017","journal-title":"J. Assoc. Phys. India"},{"key":"10.1016\/j.micpath.2024.107116_bib248","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1021\/acs.cgd.9b00313","article-title":"Isoniazid-resveratrol cocrystal: a novel alternative for topical treatment of cutaneous tuberculosis","volume":"19","author":"Rosa","year":"2019","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.micpath.2024.107116_bib249","doi-asserted-by":"crossref","first-page":"907","DOI":"10.13005\/bbra\/3142","article-title":"Screening of phytochemicals from Derris indica for antimycobacterial potential using molecular docking analysis","volume":"20","author":"Kashyap","year":"2023","journal-title":"Biosci. Biotechnol. Res. Asia"},{"key":"10.1016\/j.micpath.2024.107116_bib250","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3390\/antiox10121990","article-title":"Potential anti-Mycobacterium tuberculosis activity of plant secondary metabolites: insight with molecular docking interactions","volume":"10","author":"Kumar","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.micpath.2024.107116_bib251","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1056\/NEJMsb022858","article-title":"Botanical medicines--the need for new regulations","volume":"347","author":"Marcus","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2024.107116_bib252","first-page":"607","article-title":"Time for a new approach for reporting herbal medicine adverse events?, J. Altern. Complement","volume":"9","author":"Peters","year":"2003","journal-title":"Med. N. Y. N"},{"key":"10.1016\/j.micpath.2024.107116_bib253","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1749-8546-3-7","article-title":"Chemical markers for the quality control of herbal medicines: an overview","volume":"3","author":"Li","year":"2008","journal-title":"Chin. Med."},{"key":"10.1016\/j.micpath.2024.107116_bib254","unstructured":"M.M. Robinson, X. Zhang, THE WORLD MEDICINES SITUATION 201, (n.d.)."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401024005837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401024005837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T21:22:11Z","timestamp":1733952131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401024005837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":254,"alternative-id":["S0882401024005837"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2024.107116","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights to the role of phytoconstituents in aiding multi drug resistance \u2013 Tuberculosis treatment strategies","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2024.107116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107116"}}